{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:53Z","timestamp":1793413493554,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Initiative d'Excellence d'Universit\u00e9 C\u00f4te d'Azur bearing the reference ANR-15-IDEX-01"},{"name":"R\u00e9gion Sud and the Conseil D\u00e9partemental 06"},{"DOI":"10.13039\/501100013371","name":"Universit\u00e9 C\u00f4te d\u2019Azur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013371","id-type":"DOI","asserted-by":"crossref"}]},{"name":"LABEX (excellence laboratory, program investment for the future) DISTALZ"},{"DOI":"10.13039\/100014808","name":"Fondation Vaincre Alzheimer","doi-asserted-by":"crossref","award":["FR18-035"],"award-info":[{"award-number":["FR18-035"]}],"id":[{"id":"10.13039\/100014808","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003750","name":"Association France Alzheimer","doi-asserted-by":"crossref","award":["6174"],"award-info":[{"award-number":["6174"]}],"id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01772-0","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:22:23Z","timestamp":1748845343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hampered AMPK-ULK1 cascade in Alzheimer\u2019s disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metformin"],"prefix":"10.1186","volume":"17","author":[{"given":"Arnaud","family":"Mary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Barale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Eysert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lacas-Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Eddarkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bu\u00e9e-Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Checler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounia","family":"Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"1772_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/alz.12256","volume":"17","author":"M Audrain","year":"2021","unstructured":"Audrain M, Haure-Mirande JV, Mleczko J, Wang M, Griffin JK, St George-Hyslop PH, Fraser P, Zhang B, Gandy S, Ehrlich ME. Reactive or Transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer\u2019s-related mice. Alzheimers Dement. 2021;17:149\u201363. https:\/\/doi.org\/10.1002\/alz.12256.","journal-title":"Alzheimers Dement"},{"key":"1772_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00549-x","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Dorothee G, Heneka MT. Peripheral and central immune system crosstalk in alzheimer disease - a research prospectus. Nat Rev Neurol: Doi. 2021. https:\/\/doi.org\/10.1038\/s41582-021-00549-x.","journal-title":"Nat Rev Neurol: Doi"},{"key":"1772_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-beta and Tau: the trigger and bullet in alzheimer disease pathogenesis. JAMA Neurol. 2014;71:505\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847.","journal-title":"JAMA Neurol"},{"key":"1772_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2018.06.038","volume":"71","author":"A Bourgeois","year":"2018","unstructured":"Bourgeois A, Lauritzen I, Lorivel T, Bauer C, Checler F, Pardossi-Piquard R. Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and Spatial learning deficits in 3xTgAD and 2xTgAD mice. Neurobiol Aging. 2018;71:21\u201331. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.038.","journal-title":"Neurobiol Aging"},{"key":"1772_CR5","first-page":"351","volume-title":"Structural basis of mammalian respiratory complex I Inhibition by medicinal Biguanides","author":"HR Bridges","year":"2023","unstructured":"Bridges HR, Blaza JN, Yin Z, Chung I, Pollak MN, Hirst J. Structural basis of mammalian respiratory complex I Inhibition by medicinal Biguanides. Volume 379. New York, N Y: Science; 2023. pp. 351\u20137."},{"key":"1772_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121539","author":"R Bussiere","year":"2019","unstructured":"Bussiere R, Oules B, Mary A, Vaillant-Beuchot L, Martin C, El Manaa W, Vallee D, Duplan E, Paterlini-Brechot P. Upregulation of the Sarco-Endoplasmic Reticulum Calcium ATPase 1 Truncated Isoform Plays a Pathogenic Role in Alzheimer\u2019s Disease. Cells. 2019;8. https:\/\/doi.org\/10.3390\/cells8121539. Alves Da Costa Cet al."},{"key":"1772_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2018.09.008","volume":"311","author":"JL Chen","year":"2019","unstructured":"Chen JL, Luo C, Pu D, Zhang GQ, Zhao YX, Sun Y, Zhao KX, Liao ZY, Lv AK, Zhu SY al. Metformin attenuates diabetes-induced Tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance. Exp Neurol. 2019;311:44\u201356. https:\/\/doi.org\/10.1016\/j.expneurol.2018.09.008.","journal-title":"Exp Neurol"},{"key":"1772_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-020-00761-9","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhao S, Fan Z, Li Z, Zhu Y, Shen T, Li K, Yan Y, Tian J, Liu Z al. Metformin attenuates plaque-associated Tau pathology and reduces amyloid-\u03b2 burden in APP\/PS1 mice. Alzheimers Res Ther. 2021;13:40. https:\/\/doi.org\/10.1186\/s13195-020-00761-9.","journal-title":"Alzheimers Res Ther"},{"key":"1772_CR9","doi-asserted-by":"publisher","first-page":"838173","DOI":"10.3389\/fnagi.2022.838173","volume":"14","author":"MR Du","year":"2022","unstructured":"Du MR, Gao QY, Liu CL, Bai LY, Li T, Wei FL. Exploring the Pharmacological potential of Metformin for neurodegenerative diseases. Front Aging Neurosci. 2022;14:838173. https:\/\/doi.org\/10.3389\/fnagi.2022.838173.","journal-title":"Front Aging Neurosci"},{"key":"1772_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan Xet al, et al. Mitophagy inhibits amyloid-\u03b2 and Tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci. 2019;22:401\u201312. https:\/\/doi.org\/10.1038\/s41593-018-0332-9.","journal-title":"Nat Neurosci"},{"key":"1772_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20:953\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.018.","journal-title":"Cell Metab"},{"key":"1772_CR12","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1111\/ejn.15812","volume":"56","author":"R Fujikawa","year":"2022","unstructured":"Fujikawa R, Jinno S. Identification of hyper-ramified microglia in the CA1 region of the mouse hippocampus potentially associated with stress resilience. Eur J Neurosci. 2022;56:5137\u201353. https:\/\/doi.org\/10.1111\/ejn.15812.","journal-title":"Eur J Neurosci"},{"key":"1772_CR13","doi-asserted-by":"crossref","unstructured":"Gomez-Murcia V, Launay A, Carvalho K, Burgard A, Meriaux C, Caillierez R, Eddarkaoui S, Kilinc D, Siedlecki-Wullich D. Besegher M. Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP\/PS1 mice. Brain. 2024;147: 2691\u2013705.","DOI":"10.1093\/brain\/awae113"},{"key":"1772_CR14","doi-asserted-by":"publisher","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, Cereghetti G, McGinty D, Anselmo A, Sadreyev RI, et al. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer\u2019s Disease. Neuron. 2019; 103: 820\u2013835. e827 https:\/\/doi.org\/10.1016\/j.neuron.2019.06.010","DOI":"10.1016\/j.neuron.2019.06.010"},{"key":"1772_CR15","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/s41467-021-23111-1","volume":"12","author":"A Grubman","year":"2021","unstructured":"Grubman A, Choo XY, Chew G, Ouyang JF, Sun G, Croft NP, Rossello FJ, Simmons R, Buckberry S, Landin DV al. Transcriptional signature in microglia associated with Abeta plaque phagocytosis. Nat Commun. 2021;12:3015. https:\/\/doi.org\/10.1038\/s41467-021-23111-1.","journal-title":"Nat Commun"},{"key":"1772_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-022-00552-w","volume":"17","author":"JV Haure-Mirande","year":"2022","unstructured":"Haure-Mirande JV, Audrain M, Ehrlich ME, Gandy S. Microglial TYROBP\/DAP12 in Alzheimer\u2019s disease: transduction of physiological and pathological signals across TREM2. Mol Neurodegener. 2022;17:55. https:\/\/doi.org\/10.1186\/s13024-022-00552-w.","journal-title":"Mol Neurodegener"},{"key":"1772_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-2011-101524","volume":"24","author":"CC Hsu","year":"2011","unstructured":"Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and Metformin. J Alzheimers Dis. 2011;24:485\u201393. https:\/\/doi.org\/10.3233\/JAD-2011-101524.","journal-title":"J Alzheimers Dis"},{"key":"1772_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","volume":"60","author":"P Imfeld","year":"2012","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR. Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study. J Am Geriatr Soc. 2012;60:916\u201321. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.03916.x.","journal-title":"J Am Geriatr Soc"},{"key":"1772_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay TR, Hirsch AM, Broihier ML, Miller CM, Neilson LE, Ransohoff RM, Lamb BT, Landreth GE. Disease Progression-Dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2017;37:637\u201347. https:\/\/doi.org\/10.1523\/JNEUROSCI.2110-16.2016.","journal-title":"J Neurosci"},{"key":"1772_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/mp.2016.189","volume":"22","author":"G Kaur","year":"2017","unstructured":"Kaur G, Pawlik M, Gandy SE, Ehrlich ME, Smiley JF, Levy E. Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein. Mol Psychiatry. 2017;22:981\u20139. https:\/\/doi.org\/10.1038\/mp.2016.189.","journal-title":"Mol Psychiatry"},{"key":"1772_CR21","doi-asserted-by":"publisher","first-page":"19146","DOI":"10.1074\/jbc.M115.636852","volume":"290","author":"B Kim","year":"2015","unstructured":"Kim B, Figueroa-Romero C, Pacut C, Backus C, Feldman EL. Insulin resistance prevents AMPK-induced Tau dephosphorylation through Akt-mediated increase in AMPKSer-485 phosphorylation. J Biol Chem. 2015;290:19146\u201357. https:\/\/doi.org\/10.1074\/jbc.M115.636852.","journal-title":"J Biol Chem"},{"key":"1772_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2018;4:575\u201390. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014.","journal-title":"Alzheimers Dement (N Y)"},{"key":"1772_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","volume":"31","author":"AM Koenig","year":"2017","unstructured":"Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE. Effects of the insulin sensitizer Metformin in alzheimer disease: pilot data from a randomized Placebo-controlled crossover study. Alzheimer Dis Assoc Disord. 2017;31:107\u201313. https:\/\/doi.org\/10.1097\/WAD.0000000000000202.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1772_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","volume":"79","author":"YC Kuan","year":"2017","unstructured":"Kuan YC, Huang KW, Lin CL, Hu CJ, Kao CH. Effects of Metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79:77\u201383. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.002.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1772_CR25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neuron.2019.11.010","volume":"104","author":"D Kwart","year":"2019","unstructured":"Kwart D, Gregg A, Scheckel C, Murphy EA, Paquet D, Duffield M, Fak J, Olsen O, Darnell RB, Tessier-Lavigne M. A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP beta-CTFs, not Abeta. Neuron. 2019;104:1022. https:\/\/doi.org\/10.1016\/j.neuron.2019.11.010.","journal-title":"Neuron"},{"key":"1772_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"K Labuzek","year":"2010","unstructured":"Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B. Quantification of Metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep. 2010;62:956\u201365.","journal-title":"Pharmacol Rep"},{"key":"1772_CR27","doi-asserted-by":"publisher","unstructured":"Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O et al. Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer\u2019s disease-like pathologies and cognitive deficits. Acta Neuropathol. 2017;134: 749\u2013767 https:\/\/doi.org\/10.1007\/s00401-017-1733-7","DOI":"10.1007\/s00401-017-1733-7"},{"key":"1772_CR28","doi-asserted-by":"publisher","unstructured":"Lauritzen I, Pardossi-Piquard R, Bauer C, Brigham E, Abraham JD, Ranaldi S, Fraser P, St-George-Hyslop P, Le Thuc O, Espin Vet et al. The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J Neurosci. 2012;32: 16243-11655a https:\/\/doi.org\/10.1523\/JNEUROSCI.2775-12.2012","DOI":"10.1523\/JNEUROSCI.2775-12.2012"},{"key":"1772_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","volume":"132","author":"I Lauritzen","year":"2016","unstructured":"Lauritzen I, Pardossi-Piquard R, Bourgeois A, Pagnotta S, Biferi M-G, Barkats M, Lacor P, Klein W, Bauer C, Checler F. Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology. Acta Neuropathol. 2016;132:257\u201376. https:\/\/doi.org\/10.1007\/s00401-016-1577-6.","journal-title":"Acta Neuropathol"},{"key":"1772_CR30","doi-asserted-by":"publisher","unstructured":"Lu XY, Huang S, Chen QB, Zhang D, Li W, Ao R, Leung FC, Zhang Z, Huang J, Tang Y, et al. Metformin Ameliorates A\u03b2 Pathology by Insulin-Degrading Enzyme in a Transgenic Mouse Model of Alzheimer\u2019s Disease. Oxid Med Cell Longev. 2020; 2315106 https:\/\/doi.org\/10.1155\/2020\/2315106","DOI":"10.1155\/2020\/2315106"},{"key":"1772_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, Wu J, Wei X, Qu Q, Yu Y al. Low-dose Metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603:159\u201365. https:\/\/doi.org\/10.1038\/s41586-022-04431-8.","journal-title":"Nature"},{"key":"1772_CR32","doi-asserted-by":"publisher","first-page":"eabj5559","DOI":"10.1126\/science.abj5559","volume":"380","author":"N Malik","year":"2023","unstructured":"Malik N, Ferreira BI, Hollstein PE, Curtis SD, Trefts E, Weiser Novak S, Yu J, Gilson R, Hellberg K, Fang Let al, et al. Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1. Science. 2023;380:eabj5559. https:\/\/doi.org\/10.1126\/science.abj5559.","journal-title":"Science"},{"key":"1772_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fncel.2018.00121","volume":"12","author":"S Mondragon-Rodriguez","year":"2018","unstructured":"Mondragon-Rodriguez S, Gu N, Manseau F, Williams S. Alzheimer\u2019s Transgenic model is characterized by very early brain network alterations and beta-CTF fragment accumulation: reversal by beta-Secretase Inhibition. Front Cell Neurosci. 2018;12:121. https:\/\/doi.org\/10.3389\/fncel.2018.00121.","journal-title":"Front Cell Neurosci"},{"key":"1772_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"1772_CR35","doi-asserted-by":"publisher","unstructured":"Onyango IG, Jauregui GV, Carna M, Bennett JP Jr., Stokin GB. Neuroinflammation in Alzheimer\u2019s Disease. Biomedicines. 2021;9. https:\/\/doi.org\/10.3390\/biomedicines9050524.","DOI":"10.3390\/biomedicines9050524"},{"key":"1772_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","volume":"69","author":"Z Ou","year":"2018","unstructured":"Ou Z, Kong X, Sun X, He X, Zhang L, Gong Z, Huang J, Xu B, Long D, Li J al. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice. Brain Behav Immun. 2018;69:351\u201363. https:\/\/doi.org\/10.1016\/j.bbi.2017.12.009.","journal-title":"Brain Behav Immun"},{"key":"1772_CR37","doi-asserted-by":"publisher","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","volume":"32","author":"B Oules","year":"2012","unstructured":"Oules B, Del Prete D, Greco B, Zhang X, Lauritzen I, Sevalle J, Moreno S, Paterlini-Brechot P, Trebak M, Checler F al. Ryanodine receptor Blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of alzheimer disease. J Neurosci. 2012;32:11820\u201334. https:\/\/doi.org\/10.1523\/JNEUROSCI.0875-12.2012. Doi 32\/34\/11820 [pii].","journal-title":"J Neurosci"},{"key":"1772_CR38","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1080\/15548627.2021.1898748","volume":"17","author":"M Paquette","year":"2021","unstructured":"Paquette M, El-Houjeiri L, L CZ, Puustinen P, Blanchette P, Jeong H, Dejgaard K, Siegel PM, Pause A. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy. 2021;17:3957\u201375. https:\/\/doi.org\/10.1080\/15548627.2021.1898748.","journal-title":"Autophagy"},{"key":"1772_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","volume":"298","author":"CA Peixoto","year":"2017","unstructured":"Peixoto CA, Oliveira WH, Araujo S, Nunes AKS. AMPK activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol. 2017;298:31\u201341. https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.013.","journal-title":"Exp Neurol"},{"key":"1772_CR40","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","volume":"1853","author":"P Picone","year":"2015","unstructured":"Picone P, Nuzzo D, Caruana L, Messina E, Barera A, Vasto S, Di Carlo M. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-\u03baB activation: use of insulin to attenuate Metformin\u2019s effect. Biochim Biophys Acta. 2015;1853:1046\u201359. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.01.017.","journal-title":"Biochim Biophys Acta"},{"key":"1772_CR41","doi-asserted-by":"publisher","first-page":"173290","DOI":"10.1016\/j.ejphar.2020.173290","volume":"881","author":"V Pilipenko","year":"2020","unstructured":"Pilipenko V, Narbute K, Pupure J, Langrate IK, Muceniece R, Klu\u0161a V. Neuroprotective potential of antihyperglycemic drug Metformin in streptozocin-induced rat model of sporadic Alzheimer\u2019s disease. Eur J Pharmacol. 2020;881:173290. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173290.","journal-title":"Eur J Pharmacol"},{"key":"1772_CR42","doi-asserted-by":"publisher","unstructured":"Pinto B, Morelli G, Rastogi M, Savardi A, Fumagalli A, Petretto A, Bartolucci M, Varea E, Catelani T, Contestabile Aet et al. Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome. Neuron. 2020; 108: 887\u2013904 e812 https:\/\/doi.org\/10.1016\/j.neuron.2020.09.010","DOI":"10.1016\/j.neuron.2020.09.010"},{"key":"1772_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jalz.2019.09.002","volume":"16","author":"MV Pulina","year":"2020","unstructured":"Pulina MV, Hopkins M, Haroutunian V, Greengard P, Bustos V. C99 selectively accumulates in vulnerable neurons in Alzheimer\u2019s disease. Alzheimers Dement. 2020;16:273\u201382. https:\/\/doi.org\/10.1016\/j.jalz.2019.09.002.","journal-title":"Alzheimers Dement"},{"key":"1772_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fendo.2018.00400","volume":"9","author":"C Rotermund","year":"2018","unstructured":"Rotermund C, Machetanz G, Fitzgerald JC. The therapeutic potential of Metformin in neurodegenerative diseases. Front Endocrinol (Lausanne). 2018;9:400. https:\/\/doi.org\/10.3389\/fendo.2018.00400.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1772_CR45","doi-asserted-by":"publisher","first-page":"117861","DOI":"10.1016\/j.lfs.2020.117861","volume":"255","author":"PM Saffari","year":"2020","unstructured":"Saffari PM, Alijanpour S, Takzaree N, Sahebgharani M, Etemad-Moghadam S, Noorbakhsh F, Partoazar A. Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer\u2019s disease model. Life Sci. 2020;255:117861. https:\/\/doi.org\/10.1016\/j.lfs.2020.117861.","journal-title":"Life Sci"},{"key":"1772_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/bs.mcb.2015.06.006","volume":"131","author":"P Schatzle","year":"2016","unstructured":"Schatzle P, Kapitein LC, Hoogenraad CC. Live imaging of microtubule dynamics in organotypic hippocampal slice cultures. Methods Cell Biol. 2016;131:107\u201326. https:\/\/doi.org\/10.1016\/bs.mcb.2015.06.006.","journal-title":"Methods Cell Biol"},{"key":"1772_CR47","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4.","journal-title":"Lancet"},{"key":"1772_CR48","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/glia.23032","volume":"64","author":"JE Sepulveda-Diaz","year":"2016","unstructured":"Sepulveda-Diaz JE, Ouidja MO, Socias SB, Hamadat S, Guerreiro S, Raisman-Vozari R, Michel PP. A simplified approach for efficient isolation of functional microglial cells: application for modeling neuroinflammatory responses in vitro. Glia. 2016;64:1912\u201324. https:\/\/doi.org\/10.1002\/glia.23032.","journal-title":"Glia"},{"key":"1772_CR49","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3233\/jad-151200","volume":"51","author":"SM Son","year":"2016","unstructured":"Son SM, Shin HJ, Byun J, Kook SY, Moon M, Chang YJ, Mook-Jung I. Metformin facilitates Amyloid-\u03b2 generation by \u03b2- and \u03b3-Secretases via autophagy activation. J Alzheimers Dis. 2016;51:1197\u2013208. https:\/\/doi.org\/10.3233\/jad-151200.","journal-title":"J Alzheimers Dis"},{"key":"1772_CR50","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts E, Shaw RJ. AMPK: restoring metabolic homeostasis over space and time. Mol Cell. 2021;81:3677\u201390. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.015.","journal-title":"Mol Cell"},{"key":"1772_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F, Kinoshita PF, Cazareth J, Badot C, Fragaki Ket al, et al. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol. 2021;141:39\u201365. https:\/\/doi.org\/10.1007\/s00401-020-02234-7.","journal-title":"Acta Neuropathol"},{"key":"1772_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02308-0","author":"A Valverde","year":"2021","unstructured":"Valverde A, Dunys J, Lorivel T, Debayle D, Gay AS, Lacas-Gervais S, Roques BP, Chami M, Checler F. Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer\u2019s disease (AD) mouse model and is increased at early stage in sporadic AD brain. Acta Neuropathol: Doi. 2021. https:\/\/doi.org\/10.1007\/s00401-021-02308-0.","journal-title":"Acta Neuropathol: Doi"},{"key":"1772_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxlet.2017.10.021","volume":"282","author":"H Wang","year":"2018","unstructured":"Wang H, Jiang T, Li W, Gao N, Zhang T. Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer\u2019s disease. Toxicol Lett. 2018;282:100\u20138. https:\/\/doi.org\/10.1016\/j.toxlet.2017.10.021.","journal-title":"Toxicol Lett"},{"key":"1772_CR54","doi-asserted-by":"publisher","unstructured":"Wang Y, An H, Liu T, Qin C, Sesaki H, Guo S, Radovick S, Hussain M, Maheshwari A, Wondisford FE, et al. Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell Rep. 2019;29: 1511\u20131523 e1515 https:\/\/doi.org\/10.1016\/j.celrep.2019.09.070","DOI":"10.1016\/j.celrep.2019.09.070"},{"key":"1772_CR55","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s12035-020-01955-w","volume":"57","author":"L Wang","year":"2020","unstructured":"Wang L, Li N, Shi FX, Xu WQ, Cao Y, Lei Y, Wang JZ, Tian Q, Zhou XW. Upregulation of AMPK ameliorates Alzheimer\u2019s Disease-Like Tau pathology and memory impairment. Mol Neurobiol. 2020;57:3349\u201361. https:\/\/doi.org\/10.1007\/s12035-020-01955-w.","journal-title":"Mol Neurobiol"},{"key":"1772_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegeneration. 2020;15:30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6.","journal-title":"Mol Neurodegeneration"},{"key":"1772_CR57","doi-asserted-by":"publisher","unstructured":"Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer\u2019s disease. Mol Brain. 2011;4(3). https:\/\/doi.org\/10.1186\/1756-6606-4-3.","DOI":"10.1186\/1756-6606-4-3"},{"key":"1772_CR58","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmet.2013.09.005","volume":"18","author":"YL Zhang","year":"2013","unstructured":"Zhang YL, Guo H, Zhang CS, Lin SY, Yin Z, Peng Y, Luo H, Shi Y, Lian G, Zhang C al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab. 2013;18:546\u201355. https:\/\/doi.org\/10.1016\/j.cmet.2013.09.005.","journal-title":"Cell Metab"},{"key":"1772_CR59","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s13311-022-01316-6","volume":"20","author":"S Zhao","year":"2023","unstructured":"Zhao S, Fan Z, Zhang X, Li Z, Shen T, Li K, Yan Y, Yuan Y, Pu J, Tian J al. Metformin attenuates Tau pathology in Tau-Seeded PS19 mice. Neurotherapeutics. 2023;20:452\u201363. https:\/\/doi.org\/10.1007\/s13311-022-01316-6.","journal-title":"Neurotherapeutics"},{"key":"1772_CR60","doi-asserted-by":"publisher","first-page":"154265","DOI":"10.1016\/j.metabol.2020.154265","volume":"109","author":"JB Zhou","year":"2020","unstructured":"Zhou JB, Tang X, Han M, Yang J, Simo R. Impact of antidiabetic agents on dementia risk: A bayesian network meta-analysis. Metabolism. 2020;109:154265. https:\/\/doi.org\/10.1016\/j.metabol.2020.154265.","journal-title":"Metabolism"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01772-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01772-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:22:24Z","timestamp":1748845344000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01772-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1772"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01772-0","relation":{"references":[{"id-type":"doi","id":"10.3390\/cells8121539","asserted-by":"subject"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We follow applicable international, national, and institutional guidelines for the care and use of animals. Experimental procedures performed in studies involving animals were approved by Nice university Animal care and use Committee, and the National Council on animal care of the Ministry of Health (Project n\u00b0: APAFIS#20495-201904231352370) in accordance with the guidelines established by the European community council (Directive of November 24th, 1986) and with the ethical standards and animal welfare committee of our institute.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical studies. Brain samples were obtained from the Brain Bank \u201cNeuro-CEB\u201d run by a consortium of Patients Associations: ARSEP (association for research on multiple sclerosis), CSC (cerebellar ataxias), and France Parkinson. The consents were signed by the patients themselves or their next of kin in their name, in accordance with the French Bioethical (agreement AC-2013-1887). Cases were anonymized but information was provided regarding sex, age at death, and neuropathology (Suppl.Table 1). Informed consent for tissue donation for research is obtained by the brain banks under their approval procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}